CereVasc
Develops minimally invasive eShunt System to treat communicating hydrocephalus and other neurological diseases
$85MSeries C
Role not disclosedLoading investors…
Activity from announced rounds
Develops minimally invasive eShunt System to treat communicating hydrocephalus and other neurological diseases
Develops interventional therapies for pulmonary hypertension and heart failure